Equities

vTv Therapeutics Inc

vTv Therapeutics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)14.24
  • Today's Change-0.69 / -4.62%
  • Shares traded15.39k
  • 1 Year change-15.64%
  • Beta0.6371
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments9.451213
Total Receivables, Net0.10120.06
Total Inventory------
Prepaid expenses1.042.541.91
Other current assets, total0.070.020.24
Total current assets112716
Property, plant & equipment, net0.360.560.68
Goodwill, net------
Intangibles, net------
Long term investments05.599.17
Note receivable - long term------
Other long term assets------
Total assets113325
LIABILITIES
Accounts payable4.082.461.88
Accrued expenses6.345.016.33
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.190.220.26
Other current liabilities, total0.020.020.04
Total current liabilities117.718.50
Total long term debt000
Total debt0.190.220.26
Deferred income tax------
Minority interest6.131725
Other liabilities, total19201.75
Total liabilities364435
SHAREHOLDERS EQUITY
Common stock0.031.050.90
Additional paid-in capital256254238
Retained earnings (accumulated deficit)(281)(266)(249)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity(25)(11)(9.74)
Total liabilities & shareholders' equity113325
Total common shares outstanding2.662525
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.